ouabain has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dybkova, N; Groborz, J; Gronau, P; Heinzel, FR; Kockskämper, J; Lai, FA; Maier, LS; Napolitano, C; Pieske, B; Priori, SG; Sedej, S; Vos, MA; Wakula, P; Walther, S | 1 |
| Brette, F | 1 |
| MOSEY, L; TYLER, MD | 1 |
| FAWAZ, G; TUTUNJI, B | 1 |
| ELLIS, CH | 1 |
| Awaji, T; Hashimoto, K | 1 |
| De Groot, SH; Gorgels, AP; Leunissen, JD; Lipcsei, GC; Vos, MA; Wellens, HJ | 1 |
| Abe, H; Awaji, T; Hashimoto, K; Motomura, S; Wu, Z | 1 |
| Fazekas, T; Leunissen, JD; Vos, MA; Wellens, HJ | 1 |
| Chiba, S; Furukawa, Y; Hashimoto, K; Xue, YX | 1 |
| Alexanian, AR; Arutyunian, NS; Galoyan, AA | 1 |
| De Groot, SH; Dohmen, LR; Gorgels, AP; Hermans, M; Leunissen, JD; Vos, MA; Wellens, HJ | 1 |
| Apkon, M; Berul, CI; Ingwall, JS; O'Brien, SE; Patel, HT; Saupe, K; Spindler, M; Zahler, R | 1 |
13 other study(ies) available for ouabain and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Topics: Action Potentials; Animals; Calcium; Calcium Signaling; Catecholamines; Enzyme Inhibitors; Female; Gene Knock-In Techniques; Humans; Male; Mice; Mice, Transgenic; Microscopy, Confocal; Mutation; Myocytes, Cardiac; Ouabain; Patch-Clamp Techniques; Phosphorylation; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sodium; Sodium-Potassium-Exchanging ATPase; Tachycardia, Ventricular; Thiazepines; Time Factors | 2010 |
Calcium polymorphic ventricular tachycardia: a new name for CPVT?
Topics: Action Potentials; Animals; Calcium; Calcium Signaling; Catecholamines; Enzyme Inhibitors; Gene Knock-In Techniques; Humans; Mice; Mice, Transgenic; Mutation; Myocytes, Cardiac; Ouabain; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sodium; Sodium-Potassium-Exchanging ATPase; Tachycardia, Ventricular; Terminology as Topic; Thiazepines | 2010 |
The effect of diphenylhydantoin sodium (dilantin), procaine hydrochloride, procaine amide hydrochloride, and quinidine hydrochloride upon ouabain-induced ventricular tachycardia in unanesthetized dogs.
Topics: Animals; Dogs; Hydantoins; Ouabain; Phenytoin; Procainamide; Procaine; Quinidine; Sodium; Tachycardia; Tachycardia, Ventricular | 1954 |
Ouabain-induced ventricular tachycardia and its effect on the performance and metabolism of the dog heart.
Topics: Animals; Dogs; Heart; Myocardium; Ouabain; Oxygen Consumption; Phosphocreatine; Strophanthins; Tachycardia; Tachycardia, Ventricular | 1959 |
CONTROL OF VENTRICULAR TACHYCARDIAS IN DOGS BY B.W. 62-235, A DERIVATIVE OF METHOXAMINE.
Topics: Anti-Arrhythmia Agents; Atropine; Blood Pressure; Blood Pressure Determination; Digoxin; Dogs; Epinephrine; Hydrocarbons; Methoxamine; Ouabain; Pharmacology; Quinidine; Research; Tachycardia; Tachycardia, Ventricular | 1964 |
Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Coronary Vessels; Disopyramide; Dogs; Drug Interactions; Drug Synergism; Electrophysiology; Female; Heart Rate; Infusions, Intravenous; Male; Mexiletine; Ouabain; Tachycardia, Ventricular | 1993 |
Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Cromakalim; Dogs; Electrocardiography; Female; Heart; Heart Block; Hemodynamics; Male; Ouabain; Pyrroles; Tachycardia, Ventricular; Torsades de Pointes | 1994 |
Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Epinephrine; Female; Heart Rate; Male; Myocardial Contraction; Myocardial Ischemia; Ouabain; Quinolones; Tachycardia, Ventricular; Vasodilation; Ventricular Fibrillation | 1993 |
Effects of magnesium and ethmozin on ventricular tachycardia induced by ouabain and ventricular pacing in conscious dogs with complete atrioventricular block.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart Block; Injections, Intravenous; Magnesium; Male; Moricizine; Ouabain; Tachycardia, Ventricular | 1993 |
Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias.
Topics: Animals; Benzazepines; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; Ligation; Male; Ouabain; Tachycardia, Ventricular; Vasoconstrictor Agents | 1996 |
Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Chloride; Cardiovascular Agents; Coronary Vessels; Electrocardiography; Epinephrine; Male; Ouabain; Piperidines; Rats; Rats, Wistar; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
The dynamic behavior of the diastolic slope of monophasic action potential can be related to the occurrence and maintenance of delayed afterdepolarization dependent arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Diastole; Dogs; Electrophysiology; Heart; Lidocaine; Ouabain; Tachycardia, Ventricular | 1999 |
Phenotypical features of long Q-T syndrome in transgenic mice expressing human Na-K-ATPase alpha(3)-isoform in hearts.
Topics: Animals; Cardiac Pacing, Artificial; Cells, Cultured; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Linear Models; Long QT Syndrome; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Ouabain; Phenotype; Sodium-Potassium-Exchanging ATPase; Tachycardia, Ventricular | 2000 |